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Abstract: Although precise cellular and molecular mechanisms underlying neurodegeneration
still remain enigmatic, key factors associated with degenerative disorders, such as glutamate
toxicity and oxidative stress, have been recently identified. Accordingly, there has been growing
interest in examining the effects of exogenous and endogenous molecules on neuroprotection
and neurodegeneration. In this paper, we review recent studies on neuroprotective and/or
neurodegenerative effects of natural products, such as caffeic acid and chlorogenic acid, and gaseous
mediators, including hydrogen sulfide and nitric oxide. Furthermore, possible molecular mechanisms
of these molecules in relation to glutamate signals are discussed. Insight into the pathophysiological
role of these molecules will make progress in our understanding of molecular mechanisms underlying
neurodegenerative diseases, and is expected to lead to potential therapeutic approaches.
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1. Introduction
There are a wide variety of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s
disease, and stroke, with distinct symptoms and pathologies. For many of these diseases, the vast
majority of cases are sporadic. Therefore, the need for research on pathogenesis, therapeutic agents,
and useful biomarkers are increasing. Oxidative stress is recognized as one of the critical factors in many
neurodegenerative diseases under conditions of hypoxia/ischemia [1–3]. Antioxidant compounds
derived from natural products have demonstrated neuroprotective activity in models of neuronal cell
death and neurodegeneration in vitro and in vivo [4].
Glutamate is the most common neurotransmitter in the central nervous system, and plays
an important role in signal transduction and functional regulation, including synaptic plasticity. On the
other hand, it is widely believed that glutamate may also be responsible for quite a variety of diseases
of the central nervous system. Brain injury and stroke lead to an excess of glutamate, and excessive
glutamate is actually toxic to neurons, and multiple mechanisms underlying glutamate-induced
neurotoxicity [5,6]. Accordingly, glutamate excitotoxicity, oxidative stress, and mitochondrial
dysfunction are common features that lead to neuronal cell death in cerebral ischemia, Parkinson’s
disease, and Alzheimer’s disease [2,5,6]. In ischemic stroke, neuronal excitotoxicity, caused by
increased extracellular glutamate levels, is known to result in Ca2+ overload [7]. N-methyl-D-aspartate
(NMDA) receptor, a type of the ionotropic glutamate receptor, is linked to downstream neurotoxic
proteins, such as neuronal nitric oxide synthase (nNOS), through the postsynaptic density 95 (PSD95),
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discs large, zonula occludens-1 (PDZ) domains of PSD95 [8]. The activation of nNOS leads to the
production of nitric oxide (NO) and reactive oxygen species (ROS) which, in turn, leads to neuronal cell
death [8–13]. In addition to its role in neuronal toxicity, NO, which is produced in many tissues [14],
is a signaling molecule and activates cyclic guanosine monophosphate (GMP)-dependent protein
kinase pathway [15]. In addition, NO regulates the function of various target proteins through
S-nitrosylation, a covalent reaction with a cysteine thiol group on the target protein [16–18].
There are many natural products and endogenous factors that protect neurons against cell
death. We are dependent on natural products to maintain redox homeostasis, at least in part.
Ascorbate, which is also known as vitamin C, is a radical scavenging antioxidant [19,20]. In most
mammals, ascorbate precursor 2-keto-L-glono-1,4-lactone is produced by L-glono-1,4-lactone oxidase
from L-gulono-1,4-lactone, which is derived from uridine-5′-diphosphoglucose (UDP-glucose).
Since humans and other primates have lost the ability to produce ascorbate, they are dependent on its
dietary intake. In addition to vitamin C, other natural products, such as vitamin E (tocopherols and
tocotrienols), vitamin A, and carotenoids, function as antioxidants [21]. Carotenoids, which are
produced in red or yellow fruits and vegetables, are the most abundant plant-derived compounds.
Natural polyphenols are the largest group of phytochemicals, and have antioxidant, cardioprotective,
anticancer, anti-aging, and anti-inflammatory properties [22,23]. They are found in many plants, such as
grapes, olives, and blueberries, and in plant-based foods, such as coffee, green tea, and wine [22]. In the
former part of this paper, we review the natural polyphenols caffeic acid (CA) and chlorogenic acid
(CGA) (Figure 1), and their roles in protecting neurons from excitotoxicity. CA is a known antioxidant
that is present in coffee, wine, and green tea. CGA is also a well-known antioxidant that is present in
green tea and roasted coffee. CGA protects neurons against oxidative stress and glutamate-induced
neuronal cell death.
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Glutathione (γ-glutamylcysteinylglycine) is a tripeptide comprised of glutamic acid, cysteine,
and glycine, and the most abundant endogenous cytoprotectant factor [1,24,25]. GSH, the reduced form
of glutathione, is a major endogenous antioxidant molecule with concentrations reaching millimolar
levels (1–10 mM) and micromolar levels (10–30 µM) levels, in cells and plasma, respectively [26,27].
GSH is considered to be one of the most important scavengers of ROS. In addition to GSH, many other
small, water-soluble antioxidants can also act as ROS scavengers in the cell. α-Lipoic acid is
a sulfur-containing antioxidant that is synthesized in the mitochondrion by lipoic acid synthase,
and can be absorbed from food or supplements [28,29]. Both the oxidized form (α-lipoic acid) and
reduced forms (dihydrolipoic acid; DHLA) can play a role as an antioxidant [30]. In addition to the
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natural products and small sulfur-containing molecules described above, some gaseous messengers
are reported to exert neuroprotective effects. Especially, hydrogen sulfide (H2S) is well known to play
a role in cytoprotection, in addition to its role as a signaling molecule, for instance, in facilitating the
induction of hippocampal long-term potentiation (LTP) [31]. Therefore, in this review, we also outline
endogenous gaseous mediators that regulate neuronal cell death or survival.
2. Neuroprotection by Coffee Polyphenols
2.1. Coffee Consumption and Health
Coffee is one of the most popular beverages and consists of a complex mixture of chemicals,
including caffeine, CGA, and CA [32] (Figure 1). Habitual coffee consumption has many effects on
cardiovascular health, such as the reduction of the risk of stroke and anti-inflammatory diseases [33–35].
Epidemiological studies show that habitual coffee consumption reduces the risk of ischemic
stroke [36]. A large, prospective cohort study indicates the dose-dependent inverse association
between coffee consumption and death due to heart disease, respiratory disease, and stroke [34].
A meta-analysis revealed that a consumption of three to six cups of coffee per day is inversely
associated with the risk of cardiovascular disease and stroke [37]. In addition, higher rates of coffee
consumption also reduced the risk of cardiovascular disease and strokes [37]. Larsson et al. assessed
the association between coffee consumption and the risk of stroke in a Swedish mammography
cohort [38]. In the age-adjusted analysis, there was no association between coffee consumption and
risk of stroke. However, after adjustment for smoking and other risk factors, women who consumed
1–2 cups, 3–4 cups, or >5 cups of coffee per day had a significantly lower risk of stroke compared
with those who drank <1 cup of coffee per day [38]. They also reported that coffee consumption
was associated with decreased risk of cerebral infarction [38]. In the nurses’ health study, women,
without a history of stroke, coronary heart disease, diabetes, or cancer at baseline, who regularly
consumed coffee, had a modestly reduced risk of stroke, in comparison to those who did not consume
coffee [39]. Thus, daily coffee consumption seems to be beneficial for the reduction of the risk of stroke.
2.2. Caffeic Acid
CA, one of the phenolic acids, is widely distributed in higher plants, such as grape, olives, apples,
and coffee beans. CA can act as antioxidants by scavenging free radicals [40]. Alzheimer’s disease is
a progressive neurodegenerative disorder that can be characterized pathologically by the accumulation
of amyloid plaques in the neurons of Alzheimer’s disease patients. The progressive accumulation of
β-amyloid (Aβ) forms these senile plaques. Increased production of Aβ and the aggregation of Aβ
have been reported to trigger neurotoxicity [1]. In rat pheochromocytoma PC12 cells, which are used as
a model for neurons, CA can protect cells against Aβ-induced toxicity in a dose-dependent manner [41].
CA prevents the increase of intracellular Ca2+ concentrations induced by Aβ [41], and decreases the
Aβ-induced phosphorylation of tau protein and glycogen synthase kinase-3β [41]. The inhibition
of acetylcholinesterase and butyrylcholinesterase activity has been used as a therapeutic strategy
against Alzheimer’s disease [42]. In the lysates of rat cerebral tissue, CA shows an inhibitory effect
on acetylcholinesterase and butyrylcholinesterase [43]. In addition to CA, caffeic acid phenethyl ester
(CAPE) (Figure 1) is also an antioxidant flavonoid found in propolis, which is made by honeybees
to build their hives [44,45]. CA and CAPE are known neuroprotectants against neurodegeneration.
CAPE protects cerebellar granule neurons against glutamate neurotoxicity through the inhibition
of caspase-3 activation and suppression the phosphorylation of p38 [46]. CAPE also protects
neurons against the neurotoxicity induced by MPP+ (1-methyl-4-phenylpyridinium) by increasing
the expression of growth-associated protein 43 (GAP43), synapsin I, and synaptophysin [47].
In HT22 mouse hippocampus cells, CA and CAPE show protective effects against acrolein-induced
neurotoxicity [41,48]. Kim et al. reported that CA has a protective effect in an Aβ25–35-injected
Alzheimer’s disease mouse model: CA showed an improvement of memory deficits and cognitive
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impairment [48]. They also reported that CA inhibits lipid peroxidation, which occurs due to oxidative
stress in the brain, compared with the Aβ25–35-injected control group [48]. In an animal model of
Parkinson’s disease generated by injection of 6-hydroxydopamine into the rat brain, CAPE prevents
dopaminergic neuronal cell loss [49]. Further, Liang et al. reported that CA protects cerebral damage
against ischemia-reperfusion injury in rats [50]. These reports demonstrate the neuroprotective role of
CA and CAPE, highlighting their potentials for treatment of neurodegenerative diseases.
2.3. Chlorogenic Acid
In this section, we focus on the neuroprotective effects of caffeine and CGA. Caffeine, a key
component of coffee, is a purine alkaloid. Since the chemical structure of caffeine is similar
to adenosine, caffeine is a known antagonist of adenosine receptor and blocks the regulatory
effects of adenosine, a potent endogenous neuromodulator, driving the neuroprotective effect of
caffeine [51,52]. Epidemiological studies have linked caffeine consumption to a reduced risk of
Parkinson’s disease [53,54].
CGA is one of the most abundant polyphenol compounds in coffee, which is one of the major
sources of CGA [55–57]. Moreover, CGA has a number of beneficial biological activities to reduce the
risk of human chronic diseases such as inflammation, cancer, diabetes, and cardiovascular diseases.
In addition, CGA has anti-oxidative stress property [58–61]. In a rat model of transient middle
cerebral artery occlusion (MCAO), intraperitoneal administration of CGA reduced infarct volume and
sensory-motor functional deficits [62].
Given its neuroprotective effect in PC12 cells, CGA is one of the candidate components in
coffee that may protect neurons from degeneration [59,63,64]. CGA shows a cytoprotective effect
against various oxidative stressors, such as tert-butyl hydroperoxide, hydrogen peroxide (H2O2) and
FeSO4 [64]. CGA inhibits H2O2-induced nuclear condensation and DNA fragmentation, hallmarks of
apoptotic cell death, in PC12 cells [63]. Cho et al. also reported that H2O2-induced apoptosis
might be prevented by CGA through the poly (ADP-ribose) polymerase (PARP) cleavage and the
downregulation of Bcl-XL and caspase-3 expression [63]. In PC12 cells, CGA reduces intracellular
accumulation of ROS and prevents H2O2-induced activation of JNK and p38 MAPK pathways.
Further, CGA was also found to have a direct radical scavenger effect on hydroxyl radical, by using
electron spin resonance, in combination with spin trapping techniques [61]. These results indicated
that CGA works as a ROS scavenger for neuroprotection from oxidative stress. Further, CGA protects
against apoptosis that is induced by methylmercury (MeHg) in PC12 cells [59]. MeHg is a highly
neurotoxic chemical and induces ROS formation in the brain [59,65,66]. Since MeHg-induced
neurotoxicity in neuronal culture is blocked by antioxidants and NMDA receptor antagonists,
CGA protects neurons from MeHg by scavenging ROS and/or blocking glutamate receptor. There are
also other reports about the neuroprotective effects of CGA in primary cultured neurons from mice or
rats. CGA and its metabolite m-coumaric acid promotes neuronal differentiation and induce neurite
outgrowth in primary cultures derived from rat fetal hippocampus [67]. In our work, primary cultured
neurons derived from mouse cerebral cortex, CGA protected neurons from glutamate-induced neuronal
cell death [68]. We performed double staining with propidium iodide (PI) and Hoechst 33342 for
identification of late neuronal cell death by glutamate. PI is a commonly used marker to detect
apoptotic/necrotic cells. The number of PI-positive cells was increased by application of glutamate
(Figure 2A,B) [68]. However glutamate-induced neuronal cell death was attenuated in the presence of
CGA (Figure 2A,B) [68]. These results indicated that CGA protects neurons from glutamate-induced
neuronal cell death. [68]. We also analyzed the morphology of neurons by using anti-β-III tubulin
antibody. Glutamate-treated neurons had short, shrunken neurites (Figure 2C,D). The length of
dendrites was reduced by treatment with glutamate and this reduction was reversed by CGA
administration (Figure 2C,D). CGA decreases the influx of Ca2+ through the glutamate receptors [68].
These results suggest that CGA can protect neurons by inhibiting glutamate receptors, which, in turn,
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inhibits the excessive influx of intracellular Ca2+ [68]. Thus, CGA may be a potent therapeutic agent
for the prevention of neuronal cell death caused by ischemic stroke.Int. J. Mol. Sci. 2016, 17, 1652 5 of 14 
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3. Neuroprotection by H2S
3.1. H2S and Polysulfide
H2S, which is well known as a toxic gas, is a signaling molecule. It is detected at relatively
high concentrations in the brain [71–73]. In addition to its role as a signaling molecule, H2S is also
a kno n cytoprot ctant.
H2S is produced from L-cysteine, via the following enzymes: cystathionine β-synthase (CBS),
cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3MST) along with cysteine
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aminotransferase (CAT) [31,74,75]. Thioredoxin (Trx) and dihydrolipoic acid (DHLA) are endogenous
reducing cofactors that drive H2S release from 3MST [76]. H2S is also produced from D-cysteine by
3MST along with D-amino acid oxidase (DAO) [77]. Hydrogen polysulfides (H2Sn; where n = 3–7;
n = 2 is termed as persulfide) are potential H2S-derived signaling molecules, which have a higher
number of sulfane sulfur atoms than H2S [78,79]. In the brain, H2S3 and H2S are produced from
3-mercaptopyruvate (3MP) by 3MST [79].
H2S functions as a neuromodulator in the brain. It enhances the activity of NMDA receptors and
facilitates the induction of hippocampal LTP, a synaptic model of memory [31]. H2S induces Ca2+ waves
in primary cultured astrocytes by increasing intracellular concentrations of Ca2+ [80]. In blood vessel,
H2S, which is released from endothelial cells, relaxes vascular smooth muscle [74,81–83]. There are
also some studies indicating the influence of H2S on blood pressure in vivo; although, these results
remain controversial [82,84].
3.2. Neuroprotective Effect of H2S
The toxicity of H2S was recognized 300 years ago, when the Italian physician Bernardino
Ramazzini, who is known as the father of Occupational Medicine, published an account of H2S
poisoning in 1713. However, interestingly, H2S also has cytoprotectant properties.
In primary rat cortical neurons, H2S protects neurons against glutamate toxicity [85].
Glutamate can induce cell death by decreasing the total levels of glutathione (GSH and GSSG,
the reduced form), a major anti-oxidant. H2S can recover glutamate-induced decreases of intracellular
glutathione concentrations [85]. H2S enhances the activity of γ-glutamylcysteine synthetase to
produce γ-glutamylcysteine, a substrate of glutathione synthetase [85]. H2S enhances the activity
of cystine/cysteine antiporter and increases cysteine transport into the neurons, which also
leads to the increase in the levels of γ-glutamylcysteine and glutathione [85,86]. In the murine
neuroblastoma Neuro2a cells expressing a mitochondrial H2S-producing enzymes 3MST and CAT,
showed a significant resistance to oxidative glutamate toxicity, compared with cells transformed with
empty vector [86]. H2S also protected fetal brain cells by reinstating glutathione levels, which were
previously decreased by ischemia-reperfusion in utero [86]. These results indicated that H2S protects
neurons by increasing the levels of glutathione and directly suppressing ROS in the mitochondria.
In the glial cell line SH-SY5Y, H2S scavenges peroxynitrite and oxidant hypochlorous acid (HOCl)
and protects cells against peroxynitrite- and HOCl-mediated oxidative damage [87,88].
In addition, H2S is known to inhibit apoptosis. Using a model of myocardial ischemia-reperfusion,
it was reported that H2S limits myocardial infarct size, and preserves left ventricular structure and
function in vivo [89]. H2S reduces cardiomyocyte apoptosis in vitro and in vivo after myocardial
ischemia-reperfusion [89]. It increases the nuclear localization of nuclear factor erythroid-2 related
factor 2 (Nrf2), a key regulator of the antioxidant response to protect against oxidative stress [90–92].
In cultured mouse neuroblastoma Neuro2A cells, polysulfide exerts a protective effect against
t-buthylhydroperoxide-induced damage through Nrf2 signaling [93].
In the mouse hippocampal cell line HT22, H2S protects neurons from oxidative glutamate
toxicity by activating ATP-dependent K+ (KATP) channels to stabilize the membrane potential [94].
This cytoprotective mechanism of H2S is also seen in the cardiomyocyte ischemic-reperfusion injury
model [95]. H2S also enhances the cystic fibrosis transmembrane conductance regulator (CFTR) Cl−
channel [94]. The activation of KATP and CFTR Cl− channels by H2S is considered to be independent
of the increase in the GSH levels.
H2S producing ubiquitous enzymes 3MST and CAT are also localized retinal neurons, and the
production of H2S by these enzymes is regulated in a Ca2+-dependent manner [96]. H2S production is
maximal at low concentrations of Ca2+ (~10 nM) [96]. There is no change in the activity of 3MST/CAT
pathway in the presence or absence of calmodulin or a calmodulin inhibitor [96]. H2S suppresses
voltage-gated Ca2+ channels in photoreceptor cells by decreasing pH through that activation of
vacuolar-type H+-ATPase (V-ATPase) in horizontal cells. This in turn leads to the maintenance of
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intracellular Ca2+ in photoreceptor cells at low levels [96]. Excess, strong, long-time light exposure
induces retinal degeneration by ROS and the elevation of intracellular concentrations of Ca2+ [97,98].
The elevation of intracellular Ca2+ results in the inhibition of H2S production, thus reducing its
protective effects, thereby inducing damage to photoreceptor cells. However, in such conditions,
the intraperitoneal administration of an H2S donor can suppress photoreceptor cell death [96].
The light-induced increase of TUNEL- and 8-hydroxy-2′-deoxyguanosine positive cells was decreased
by the administration of H2S [96]. H2S protects photoreceptor cells from light-induced retinal
degeneration. These reports further indicate a neuroprotective effect of H2S, providing a basis for its
therapeutic use for neurodegeneration.
4. Neuronal Cell Death by NO
4.1. Nitric Oxide-Induced Calcium Release (NICR)
NO is a gaseous signaling molecule that is as equally important as Ca2+. At least three distinct
isoforms of the NOS enzyme are known: including neuronal nitric oxide synthase (nNOS, NOS1),
endothelial nitric oxide synthase (eNOS, NOS3), and inducible nitric oxide synthase (iNOS, NOS2) [99].
The first two enzyme isoforms, nNOS and eNOS are activated by elevated intracellular Ca2+ [100].
The nNOS isoform is mainly expressed in neurons. The important physiological role of NO that was
first identified was its role in the relaxation of blood vessels, following NO release from vascular
endothelial cells. NO has been recently shown to be involved in a variety of physiological and
pathophysiological functions, including synaptic plasticity and neuronal cell death, in a range of cell
types [101,102].
NO activates soluble guanylyl cyclase and subsequent cyclic GMP signaling [103]. NO signaling
also regulates other downstream signaling pathways: for instance, it regulates the function of target
proteins through the S-nitrosylation of cysteine residues [16,104,105]. An increasing number of studies
demonstrate the S-nitrosylation of proteins by NO, illustrating the important role it plays in a wide
range of signaling pathways [18,105].
Ryanodine receptor (RyR) is one of the target proteins that undergoes S-nitrosylation [106].
RyRs are large tetrameric channels that control the release of Ca2+ from the endoplasmic and
sarcoplasmic reticula [107]. Three isoforms (RyR1, RyR2, and RyR3) have been isolated in mammalian
tissues. Type 1 RyR (RyR1) is physiologically regulated by voltage-gated Ca2+ channels through direct
protein–protein interactions in excitation–contraction coupling in skeletal muscle. However, in cardiac
muscle, the opening of type 2 RyR (RyR2) is regulated by an influx of Ca2+ via voltage-gated Ca2+
channels through the Ca2+-induced Ca2+ release (CICR) mechanism [107]. Further, RyR1 is also
expressed in the brain, where we recently identified another mode of intracellular Ca2+ mobilization
mediated by RyR: the NO-induced Ca2+ release (NICR), which is dependent on the S-nitrosylation of
RyR1 at cysteine 3635 [108]. In Purkinje cells in acute cerebellar slices, NICR is induced by physiological
patterns of neuronal activity, and is essential for the induction of cerebellar LTP, which is the reverse
process of cerebellar long-term depression (LTD) [108,109]
4.2. Involvement of NICR in NO-Induced Neuronal Cell Death
The nNOS-dependent generation of NO is implicated in cerebral ischemia [110]. The NO
concentration is estimated to reach micromolar levels in ischemic cerebral tissue, during and
after MCAO [111]. Indeed, brain injury after MCAO is significantly milder in mice treated with
a nNOS-specific inhibitor and in Nos1−/− mice [112]. Further, infarct volume occurring after ischemia
reperfusion was reduced by the administration of dantrolene, a RyR inhibitor [108]. These results
suggest that nNOS, as well as RyR, are involved in ischemic brain injury, and NICR, dependent on
both nNOS and RyR1, may play a role in ischemic brain injury following reperfusion in the MCAO
model [108]. Actually, NICR exacerbates neuronal cell death in the hippocampal CA3 region of kainic
acid-induced seizures [113] (Figure 3).
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Currently, neuronal cell death by cerebral ischemia is suggested to be induced by the following
orders: (1) glutamate release; (2) Ca2+ influx-mediated glutamate receptor; (3) NO production by
NOS activation; and (4) activation of NO signaling [8,11]. Glutamate-induced neurotoxicity is
Ca2+-dependent and is mainly mediated through the activation of NMDA receptors [5]. The NO
donor induced an increase in intracellular Ca2+ in cerebral neurons, and the response was abolished in
the presence of dantrolene or in Ryr1−/− mice. There was a significant increase in cerebral neuron
death after treatment with an NO donor. In the presence of dantrolene, the NO donor-induced
neuronal cell death was significantly attenuated [108]. Therefore, NICR is, at least in part, involved in
NO-induced neuronal cell death [108]. Conversely, there was little effect of CGA on NO-induced cell
death [68]. It is suggested that the effects of CGA do not affect the downstream pathway of NO leading
to the ischemic brain injury (Figure 3). It is also interesting to note that NICR might be involved in
mitochondrial dysfunction [113]. The modulation of NO pathways could prevent oxidative damage to
neurons, via the inhibition of apoptosis, which is partly induced by NICR.
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Although the etiology of main neurodegenerative diseases is not fully understood yet, glutamate 
is indicated to be one of the most convincing factors involved in the oxidative stress process that 
underlies these illnesses. In this paper, we reviewed the neuroprotective and/or neurodegenerative 
effects of natural products and gaseous mediators. In many case, these molecules affects glutamate-
evoked events leading to neuronal cell death. For example, CGA in coffee can inhibit glutamate 
receptors, thus, playing a neuroprotective role by inhibiting the excessive increase of intracellular Ca2+. 
H2S protects neurons from glutamate-induced cell death by recovering the levels of GSH, a major 
antioxidant, and suppressing the effects of ROS. On the other hand, NO, whose production is initiated 
by the activation of NMDA receptors by glutamate, induced neurodegenerative effects through NO-
induced Ca2+ release. Therefore, the developments of drugs mimicking the neuroprotective effects of 
the natural products or H2S, or specifically inhibiting the neurodegenerative effects by NO, may be 
beneficial for the therapeutic treatment of neurodegenerative diseases. 
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Figure 3. Effects of natural products and gaseous mediators on neuronal cell death. The N-methyl-D-
aspartate receptor (NMDAR) is linked to downstream molecules, such as nitric oxide synthase (NOS).
The activation of NOS leads to the production of nitric oxide (NO), which induces Ca2+ release from
the endoplasmic reticulum (ER) through S-nitrosylation of the type 1 ryanodine receptor (RyR1) and
exacerbates neuronal cell death (red arrow). CGA inhibits NMDAR and subsequent influx of Ca2+ into
the neuronal cytosol (blue arrow), and prevents cell death. Hydrogen sulfide (H2S) protects neurons
by increasing the levels of glutathione (GSH) and directly suppressing ROS in the mitochondria
(green arrow). Abbreviations: Glu, glutamate; NICR, NO-induced Ca2+ release; CGA, chlorogenic acid;
ROS, reactive oxygen species.
5. Conclusions
Although the etiology of main neurodegenerative diseases is not fully understood yet, glutamate is
indicated to be one of the most convincing factors involved in the oxidative stress process that underlies
these illnesses. In this paper, we reviewed the neuroprotective and/or neurodegenerative effects of
natural products and gaseous mediators. In many case, these molecules affects glutamate-evoked
events leading to neuronal cell death. For example, CGA in coffee can inhibit glutamate receptors, thus,
playing a neuroprotective role by inhibiting the excessive increase of intracellular Ca2+. H2S protects
neurons from glutamate-induced cell death by recovering the levels of GSH, a major antioxidant,
and suppressing the effects of ROS. On the other hand, NO, whose production is initiated by the
activation of NMDA receptors by glutamate, induced neurodegenerative effects through NO-induced
Ca2+ release. Therefore, the developments of drugs mimicking the neuroprotective effects of the natural
products or H2S, or specifically inhibiting the neurodegenerative effects by NO, may be beneficial for
the therapeutic treatment of neurodegenerative diseases.
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CAPE Caffeic acid phenethyl ester
CAT Cysteine aminotransferase
CBS Cystathionine β-synthase
CFTR Cystic fibrosis transmembrane conductance regulator
CGA Chlorogenic acid
CICR Calcium-induced calcium release
CSE Cystathionine γ-lyase
DAO D-amino acid oxidase
DHLA Dihydrolipoic acid
eNOS Endothelial nitric oxide synthase
ER Endoplasmic reticulum
H2S Hydrogen sulfide
iNOS Inducible nitric oxide synthase
MCAO Middle cerebral artery occlusion
MeHg Methylmercury
NICR Nitric oxide-induced calcium release
NMDA N-methyl D-aspartate
nNOS Neuronal nitric oxide synthase
NO Nitric oxide
NOS Nitric oxide synthase
Nrf2 Nuclear factor erythroid-2 related factor 2
PI Propidium iodide
ROS Reactive oxygen species
RyR Ryanodine receptor
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